Scientific Advisory Council

Robert H. Vonderheide, MD, DPhil

University of Pennsylvania

Philadelphia, PA

Dr. Robert H. Vonderheide is the co-leader of the Immunobiology Program, the vice chief for Research, the Hanna Wise Professor in Cancer Research, and the director of the Abramson Cancer Center at the University of Pennsylvania.

Dr. Vonderheide is an expert in immunobiology, and his work explores how CD40, GM-CSF, PD-1, CTLA-4, and CD25 regulate the tumor environment and immune activity. He has also helped translate his work into novel immunotherapies, including vaccines, antibodies, and adoptive T cells, which have been used to treat patients with melanoma, pancreatic cancer, and other cancers. In addition to being a member of CRI’s Scientific Advisory Council, Dr. Vonderheide serves on the CLIP Grant Review Committee and is a member of CRI’s Clinical Leadership Committee.

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.